Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
Indiana Republicans File Bill to Create Statewide Regulatory System for “Craft Hemp”
A trio of Indiana House Republicans filed legislation today that would establish a comprehensive regulatory framework for craft hemp products, including flower, beverages and low-THC hemp extracts.
New Mexico Cannabis Sales Top $48 Million in December, Bringing 2025 Total to $568 Million
New Mexico’s legal marijuana market generated $48.4 million in combined sales during December, pushing the state’s total for 2025 to roughly $568 million.
Indiana: Legislation to Decriminalize Marijuana Possession Filed in House of Representatives
Legislation that would decriminalize the possession of up to two ounces of cannabis was filed today in the Indiana House of Representatives.
Study: CBD Triggers Cancer Cell Death and Suppresses Melanoma Spread Through Epigenetic Pathway
A study published Sunday by the journal Phytomedicine reports that the cannabis compound cannabidiol (CBD) demonstrated strong anti-tumor activity against melanoma by activating an epigenetic pathway that promotes cancer cell death and limits metastasis. The research was conducted by scientists from Kunming Medical University and the National University of Defense Technology.
Rhode Island Marijuana Sales Top $120 Million in 2025, Over 3.4 Million Total Transactions
Rhode Island’s regulated marijuana market generated $120,095,191 in total retail sales during 2025, a slight uptick from the $118 million sold in 2024, according to the Cannabis Control Commission. The figure includes both adult-use and medical marijuana purchases and reflects a market that has largely stabilized after its early expansion phase.
Cannabidiol Shows Promise in Easing Benzodiazepine Withdrawal Symptoms, Study Finds
A recently published study finds that cannabidiol (CBD), a non-psychoactive compound found in cannabis, can help reduce anxiety, hyperactivity and other symptoms associated with benzodiazepine withdrawal, a condition that remains difficult to treat and is considered a growing public health concern.
Massachusetts: Marijuana Sales Reach $1.8 Billion in 2025, Generating $280 Million in Tax Revenue
In Massachusetts, legal marijuana sales climbed to around $1.8 billion in 2025, pushing the state’s combined adult-use and medical market to a new annual high and easily surpassing the roughly $1.65 billion recorded in 2024.
CBD Improves Cognitive Recovery After Traumatic Brain Injury by Blocking Neuronal Oxidative Stress, Study Finds
A new study published by the peer-reviewed Phytomedicine reports that cannabidiol (CBD) significantly reduced cognitive impairment following traumatic brain injury (TBI) by protecting neurons from oxidative stress and programmed cell death. The research was conducted by scientists from Shengjing Hospital of China Medical University and identifies a previously unrecognized molecular pathway through which CBD exerts …
Study: CBD Reduces Neuroinflammation Linked to Long COVID by Modulating Brain Cell Signaling
A new study published by Neuroscience Applied suggests that cannabidiol (CBD) may help reduce neuroinflammation linked to long COVID by altering the inflammatory signals carried between brain cells.
Study: CBD May Slow Aging in Stem Cells Used for Regenerative Medicine
A study published by In Vivo reports that cannabidiol (CBD) may help delay cellular aging in mesenchymal stem cells, potentially improving their usefulness in regenerative medicine.
Sponsored
